Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Reliability and correlation of mixture cell correction in methylomic and transcriptomic blood data.

Chaumette B, Kebir O, Dion PA, Rouleau GA, Krebs MO.

BMC Res Notes. 2020 Feb 12;13(1):74. doi: 10.1186/s13104-020-4936-2.

2.

Kleptomania treated with naltrexone in a patient with intellectual disability

Mouaffak F, Hamzaoui S, Kebir O, Laqueille X.

J Psychiatry Neurosci. 2020 Jan 1;45(1):71-72. doi: 10.1503/jpn.190064. No abstract available.

3.

Psychiatric symptoms and quality of life in older adults with schizophrenia spectrum disorder: results from a multicenter study.

Hoertel N, Rotenberg L, Blanco C, Pascal de Raykeer R, Hanon C, Kaladjian A, Limosin F; CSA Study Group.

Eur Arch Psychiatry Clin Neurosci. 2019 May 27. doi: 10.1007/s00406-019-01026-9. [Epub ahead of print]

PMID:
31134378
4.

Perinatal Exposure to Environmental Endocrine Disruptors in the Emergence of Neurodevelopmental Psychiatric Diseases: A Systematic Review.

Rivollier F, Krebs MO, Kebir O.

Int J Environ Res Public Health. 2019 Apr 12;16(8). pii: E1318. doi: 10.3390/ijerph16081318.

5.

Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders.

Krebs MO, Kebir O, Jay TM.

Eur J Pain. 2019 Aug;23(7):1225-1233. doi: 10.1002/ejp.1377. Epub 2019 Mar 19. Review.

PMID:
30793421
6.

Alpha-lipoic acid in the treatment of psychiatric and neurological disorders: a systematic review.

de Sousa CNS, da Silva Leite CMG, da Silva Medeiros I, Vasconcelos LC, Cabral LM, Patrocínio CFV, Patrocínio MLV, Mouaffak F, Kebir O, Macedo D, Patrocínio MCA, Vasconcelos SMM.

Metab Brain Dis. 2019 Feb;34(1):39-52. doi: 10.1007/s11011-018-0344-x. Epub 2018 Nov 22.

PMID:
30467770
7.

Neuroprotective evidence of alpha-lipoic acid and desvenlafaxine on memory deficit in a neuroendocrine model of depression.

de Sousa CNS, Meneses LN, Vasconcelos GS, da Silva Medeiros I, Silva MCC, Mouaffak F, Kebir O, da Silva Leite CMG, Patrocinio MCA, Macedo D, Vasconcelos SMM.

Naunyn Schmiedebergs Arch Pharmacol. 2018 Aug;391(8):803-817. doi: 10.1007/s00210-018-1509-1. Epub 2018 May 7.

PMID:
29732526
8.

Epigenetic variability in conversion to psychosis: novel findings from an innovative longitudinal methylomic analysis.

Kebir O, Chaumette B, Krebs MO.

Transl Psychiatry. 2018 Apr 26;8(1):93. doi: 10.1038/s41398-018-0138-2.

9.

Longitudinal Analyses of Blood Transcriptome During Conversion to Psychosis.

Chaumette B, Kebir O, Pouch J, Ducos B, Selimi F; ICAAR study group, Gaillard R, Krebs MO.

Schizophr Bull. 2019 Jan 1;45(1):247-255. doi: 10.1093/schbul/sby009.

10.

ABCB1 C3435T polymorphism is associated with tetrahydrocannabinol blood levels in heavy cannabis users.

Kebir O, Lafaye G, Blecha L, Chaumette B, Mouaffak F, Laqueille X, Benyamina A.

Psychiatry Res. 2018 Apr;262:357-358. doi: 10.1016/j.psychres.2017.09.006. Epub 2017 Sep 9.

PMID:
28917442
11.

Naltrexone in the Treatment of Broadly Defined Behavioral Addictions: A Review and Meta-Analysis of Randomized Controlled Trials.

Mouaffak F, Leite C, Hamzaoui S, Benyamina A, Laqueille X, Kebir O.

Eur Addict Res. 2017;23(4):204-210. doi: 10.1159/000480539. Epub 2017 Sep 7. Review.

12.

[Genetics and epigenetics of schizophrenia and other psychoses].

Chaumette B, Kebir O, Krebs MO.

Biol Aujourdhui. 2017;211(1):69-82. doi: 10.1051/jbio/2017015. Epub 2017 Jul 6. Review. French.

PMID:
28682228
13.

Methylomic changes in individuals with psychosis, prenatally exposed to endocrine disrupting compounds: Lessons from diethylstilbestrol.

Rivollier F, Chaumette B, Bendjemaa N, Chayet M, Millet B, Jaafari N, Barhdadi A, Lemieux Perreault LP, Provost S, Dubé MP, Gaillard R, Krebs MO, Kebir O.

PLoS One. 2017 Apr 13;12(4):e0174783. doi: 10.1371/journal.pone.0174783. eCollection 2017.

14.

Altered cortical processing of motor inhibition in schizophrenia.

Lindberg PG, Térémetz M, Charron S, Kebir O, Saby A, Bendjemaa N, Lion S, Crépon B, Gaillard R, Oppenheim C, Krebs MO, Amado I.

Cortex. 2016 Dec;85:1-12. doi: 10.1016/j.cortex.2016.09.019. Epub 2016 Sep 30.

PMID:
27770667
15.

Paradoxical Improvement of Schizophrenic Symptoms by a Dopaminergic Agonist: An Example of Personalized Psychiatry in a Copy Number Variation-Carrying Patient.

Alexandre C, Chaumette B, Martinez G, Christa L, Dupont JM, Kebir O, Gaillard R, Amado I, Krebs MO.

Biol Psychiatry. 2016 Aug 15;80(4):e21-e23. doi: 10.1016/j.biopsych.2015.09.017. Epub 2015 Oct 8. No abstract available.

PMID:
26602590
16.

Salivary cortisol in early psychosis: New findings and meta-analysis.

Chaumette B, Kebir O, Mam-Lam-Fook C, Morvan Y, Bourgin J, Godsil BP, Plaze M, Gaillard R, Jay TM, Krebs MO.

Psychoneuroendocrinology. 2016 Jan;63:262-70. doi: 10.1016/j.psyneuen.2015.10.007. Epub 2015 Oct 16.

PMID:
26520686
17.

Family-based association study of common variants, rare mutation study and epistatic interaction detection in HDAC genes in schizophrenia.

Kebir O, Chaumette B, Fatjó-Vilas M, Ambalavanan A, Ramoz N, Xiong L, Mouaffak F, Millet B, Jaafari N, DeLisi LE, Levinson D, Joober R, Fañanás L, Rouleau G, Dubertret C, Krebs MO.

Schizophr Res. 2014 Dec;160(1-3):97-103. doi: 10.1016/j.schres.2014.09.029. Epub 2014 Oct 18.

PMID:
25445625
18.

Is baclofen a revolutionary medication in alcohol addiction management? Review and recent updates.

Gorsane MA, Kebir O, Hache G, Blecha L, Aubin HJ, Reynaud M, Benyamina A.

Subst Abus. 2012;33(4):336-49. Review.

PMID:
22989277
19.

Association of inflammation genes with alcohol dependence/abuse: a systematic review and a meta-analysis.

Kebir O, Gorsane MA, Blecha L, Krebs MO, Reynaud M, Benyamina A.

Eur Addict Res. 2011;17(3):146-53. doi: 10.1159/000324849. Epub 2011 Mar 29. Review.

PMID:
21447951
20.

Diethylstilbestrol and risk of psychiatric disorders: a critical review and new insights.

Kebir O, Krebs MO.

World J Biol Psychiatry. 2012 Feb;13(2):84-95. doi: 10.3109/15622975.2011.560280. Epub 2011 Mar 23. Review.

PMID:
21428730

Supplemental Content

Loading ...
Support Center